查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403476

到 2030 年藥品折扣卡市場預測：按類型、治療類別、銷售管道、最終用戶和地區進行的全球分析

Drug Discount Card Market Forecasts to 2030 - Global Analysis By Type, By Therapeutic Category, By Sales Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球藥品折扣卡市場規模為 2,720 萬美元，預計在預測期內將以 9.8% 的複合年成長率成長，並在 2030 年達到 5,230 萬美元。

藥品折扣卡是提供處方箋藥折扣價格的計劃。這些卡片由多種資訊來源提供，包括雇主、保險公司和患者援助計劃。節省的費用可能是巨大的，特別是對於那些沒有保險或自付額較高的人來說。

根據美國國立衛生研究院 2019 年發布的資料，只有 31% 的千禧世代了解處方箋折扣計畫。

醫療費用上漲

醫療保健成本不斷上升，增加了對負擔得起的藥物的需求。藥品折扣計劃和平台已成為為消費者提供處方藥折扣價格的重要解決方案。這些計劃彌合了藥品成本急劇上升和患者經濟困難之間的差距，確保更好地獲得基本藥物。對具有成本效益的醫療保健解決方案的需求不斷成長，加上慢性病的流行，使藥品折扣市場成為應對醫療保健行業經濟挑戰的關鍵參與者。

藥品承保範圍有限

儘管有藥物折扣計劃，但仍有大量藥物可能不在保險範圍內，使患者需要承擔高昂的自付費用。這種限制可能會對需要持續藥物治療的慢性病患者產生不成比例的影響。此外，缺乏保險覆蓋範圍阻礙了藥品折扣計劃的有效性，並限制了其提高醫療保健負擔能力的有效性。因此，患者在獲得所需藥物方面面臨經濟障礙，這可能會影響對治療計劃的遵守和整體健康結果。

與醫療保健提供者合作

醫藥企業、藥品折扣平台與醫療機構結成策略夥伴關係，幫助患者以折扣價格取得藥品。這些合作關係使醫療保健提供者能夠提供具有成本效益的處方解決方案，促進患者用藥醫囑遵從性和整體健康。此外，該合作夥伴關係還將有助於建立更精簡的醫療保健生態系統，促進提供者和藥品折扣平台之間更好的溝通和協調，並最終增加更多人獲得基本藥物的機會，提高負擔能力和可得性。

資料安全問題

該行業擴大採用數位平台和電子健康記錄來管理藥品折扣和患者資訊，從而增加了網路威脅和資料外洩的風險。詐欺存取患者資料不僅使個人隱私面臨風險，還使他們面臨資訊盜竊和詐騙的風險。此外，資料受損可能會削弱折扣計劃的有效性，並削弱消費者對醫療保健系統的信心。

COVID-19 的影響：

隨著世界各地的醫療保健系統將重點轉向大流行應對，藥品折扣市場因 COVID-19 大流行而面臨嚴重干擾。封鎖、供應鏈中斷、醫療機構就診次數減少等都影響了市場。患者在以折扣價獲得藥品方面面臨挑戰，製藥公司調整策略以應對不斷變化的情況。儘管出現了一些短期挫折，但這場大流行凸顯了負擔得起的藥品的重要性，並可能支持未來加強藥品折扣計劃的創新和政策。

零售藥房連鎖店預計將在預測期內成為最大的細分市場

零售藥局連鎖產業的市場規模預計在預測期內將會增加。這些連鎖店利用其廣泛的網路和購買力與藥品製造商協商價格，並將節省的成本轉嫁給消費者。隨著消費者尋求負擔得起的醫療保健，零售藥局連鎖店在以折扣價提供處方藥和非處方藥方面發揮重要作用。其廣泛的影響力和具有競爭力的定價為塑造藥品折扣市場形勢做出了重大貢獻，滿足了多樣化且注重成本的醫療保健消費者的需求。

線下產業預計在預測期間內複合年成長率最高

預計線下業務在預測期內將出現良好成長。這可能包括實體優惠券、藥房的面對面互動或其他獲得處方藥折扣的非數位方式。儘管線上平台越來越普及，但線下管道仍然適合那些喜歡或無法存取數位資源的個人。這種結合了線下和線上策略的雙重方法，確保了消費者在藥品折扣市場尋求具有成本效益的選擇的更廣泛的覆蓋範圍和可及性。

佔比最大的地區：

北美地區預計將佔據最大的市場佔有率。數位健康平台和處方箋折扣計劃在該地區很普及，為消費者提供藥品折扣。隨著醫療保健成本的不斷上升以及對負擔得起的治療方案的需求，北美的這些舉措旨在解決藥物醫囑遵從性的財務障礙，並確保個人獲得更好的健康結果。該地區的市場是由共同努力推動的，旨在讓更多人更容易獲得和負擔得起醫療保健。

複合年成長率最高的地區：

在預測期內，由於醫療保健成本上升、處方箋折扣意識增強以及中國和印度等國家藥品市場不斷擴大等因素，亞太地區預計將快速成長。對平價藥品的需求正在推動藥品折扣計劃的推出，使消費者和醫療保健提供者都受益。亞太地區不斷變化的醫療保健環境和對具有成本效益的解決方案的追求正在促進亞太地區藥品折扣市場的蓬勃發展，這為製藥公司和醫療保健服務供應商面臨的可及性和可負擔性挑戰提供了解決的機會。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球藥品折扣卡市場：按類型

  • 藥局社會福利經理 (PBM)
  • 零售藥局連鎖店
  • 直接面對消費者的平台
  • 非營利機構
  • 其他類型

第6章全球藥品折扣卡市場：依治療類別

  • 心血管藥物
  • 糖尿病藥物
  • 止痛藥
  • 心理健康醫學
  • 抗癌劑
  • 其他治療類別

第7章全球藥品折扣卡市場：依銷售管道

  • 線上的
  • 離線

第8章全球藥品折扣卡市場：依最終用戶分類

  • 學名藥
  • 品牌藥品
  • 特殊藥品
  • 其他最終用戶

第9章全球藥品折扣卡市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • GoodRx
  • SingleCare
  • WellCard Savings
  • RxSaver
  • Optum Perks
  • Kroger Prescription Savings Club
  • ScriptSave
  • Walmart Rx Savings Program
  • Prescription Hope
  • FamilyWize
  • NeedyMeds
  • Humana
Product Code: SMRC24701

According to Stratistics MRC, the Global Drug Discount Card Market is accounted for $27.2 million in 2023 and is expected to reach $52.3 million by 2030 growing at a CAGR of 9.8% during the forecast period. A Drug Discount Card is a program that offers reduced prices on prescription medications. These cards are offered by various sources like employers, insurance companies, and patient assistance programs. They can help individuals save significantly, especially those without insurance or high deductibles.

According to data published by National Institute of Health in 2019, only 31% of the millennial population was aware of prescription discount programs.

Market Dynamics:

Driver:

Rising healthcare costs

Healthcare expenses escalate there is an increasing need for affordable medication. Drug discount programs and platforms emerge as a crucial solution, offering consumers discounted prices on prescription medications. These programs bridge the gap between rising drug costs and the financial constraints of patients, ensuring better access to essential medications. The rising demand for cost-effective healthcare solutions, coupled with the prevalence of chronic diseases, positions the Drug Discount Market as a vital player in addressing the affordability challenges within the healthcare sector.

Restraint:

Limited drug coverage

Despite the presence of drug discount programs, a substantial number of medications may not be covered, leaving patients with high out-of-pocket expenses. This limitation can disproportionately affect individuals with chronic conditions who require ongoing medication. Additionally, the lack of coverage hampers the effectiveness of drug discount initiatives, limiting their impact on improving healthcare affordability. As a result, patients may face financial barriers to accessing essential medications, compromising their adherence to treatment plans and overall health outcomes.

Opportunity:

Partnering with healthcare providers

By forming strategic partnerships with medical institutions, pharmaceutical companies and drug discount platforms can enhance accessibility to discounted medications for patients. Such collaborations enable healthcare providers to offer cost-effective prescription solutions, promoting patient adherence and overall wellness. Additionally, partnerships contribute to a more streamlined healthcare ecosystem, fostering better communication and coordination between providers and drug discount platforms, ultimately improving the affordability and availability of essential medications for a broader population.

Threat:

Data security concerns

The industry increasingly adopts digital platforms and electronic health records for managing drug discounts and patient information, the risk of cyber threats and data breaches escalates. Unauthorized access to patient data not only jeopardizes individuals' privacy but also exposes them to potential identity theft and fraud. Moreover, compromised data integrity can undermine the efficacy of discount programs and erode consumer trust in the healthcare system.

COVID-19 Impact:

The Drug Discount Market faced significant disruptions due to the COVID-19 pandemic as healthcare systems worldwide shifted focus to pandemic response. Lockdowns, supply chain disruptions, and reduced healthcare facility visits impacted the market. Patients faced challenges in accessing discounted medications, and pharmaceutical companies adjusted their strategies to navigate the evolving landscape. Despite short-term setbacks, the pandemic underscored the importance of affordable medications, potentially driving future innovations and policies to enhance drug discount programs, making healthcare more accessible and resilient in the face of global uncertainties.

The retail pharmacy chains segment is expected to be the largest during the forecast period

Over the projection period, it is predicted that the retail pharmacy chains segment will experience a larger market size. These chains leverage their extensive network and purchasing power to negotiate lower prices from drug manufacturers, passing on the cost savings to consumers. As consumers seek affordable healthcare solutions, retail pharmacy chains play a crucial role in providing discounted prescription medications and over-the-counter drugs. Their widespread presence and competitive pricing contribute significantly to shaping the landscape of the Drug Discount Market, catering to the needs of diverse and cost-conscious healthcare consumers.

The offline segment is expected to have the highest CAGR during the forecast period

During the forecast period, it is expected that the offline segment will experience lucrative growth. This may involve physical coupons, in-person interactions at pharmacies, or other non-digital means of obtaining discounts on prescription medications. Despite the increasing prevalence of online platforms, offline channels remain relevant for individuals who prefer or have limited access to digital resources. This dual approach, combining both offline and online strategies, ensures a broader reach and accessibility for consumers seeking cost-effective options in the Drug Discount market.

Region with largest share:

The North America region is expected to witness largest market share. The region witnesses the proliferation of digital health platforms and prescription discount programs, offering consumers discounted prices on pharmaceuticals. With rising healthcare expenses and the need for affordable treatment options, these initiatives in North America aim to address financial barriers to medication adherence, ensuring better health outcomes for individuals. The market is driven by a concerted effort to make healthcare more accessible and affordable for a broader population in the region.

Region with highest CAGR:

During the forecast period, a rapid growth rate is anticipated in the Asia-Pacific region due to factors such as rising healthcare expenditures, increasing awareness of prescription discounts, and expanding pharmaceutical markets in countries like China and India. The demand for affordable medications has fuelled the adoption of drug discount programs, benefiting both consumers and healthcare providers. The region's evolving healthcare landscape and the pursuit of cost-effective solutions contribute to the thriving Drug Discount Market in Asia Pacific, offering opportunities for pharmaceutical companies and healthcare service providers to address accessibility and affordability challenges.

Key players in the market:

Some of the key players in Drug Discount Card market include GoodRx, SingleCare, WellCard Savings, RxSaver, Optum Perks, Kroger Prescription Savings Club, ScriptSave, Walmart Rx Savings Program, Prescription Hope, FamilyWize, NeedyMeds and Humana.

Key Developments:

In September 2023, GoodRx, a U.S.-based healthcare company that operates a telemedicine platform and free-to-use website and mobile app that track prescription drug prices, announced a partnership with MedImpact, an independent, trend-focused pharmacy benefit manager (PBM), to integrate its drug coupons at the point of sale.

In July 2023, CVS Caremark, a CVS Health company and GoodRx, a leading resource for healthcare savings and information, announced the launch of Caremark Cost SaverTM to help lower pharmacy out-of-pocket drug costs for CVS Caremark clients' members.

In January 2023, Amazon Pharmacy, the company offering free, two-day home delivery of prescriptions to Amazon Prime subscribers introduced RxPass a US$5 prescription subscription new Prime membership benefit from Amazon Pharmacy that provides patients with affordable access to generic medications that treat more than 80 common health conditions for just US$5 a month.

Types Covered:

  • Pharmacy Benefit Managers (PBMs)
  • Retail Pharmacy Chains
  • Direct-to-Consumer Platforms
  • Non-Profit Organizations
  • Other Types

Therapeutic Categories Covered:

  • Cardiovascular drugs
  • Diabetes drugs
  • Pain medications
  • Mental health medications
  • Cancer drugs
  • Other Therapeutic Categories

Sales Channels Covered:

  • Online
  • Offline

End Users Covered:

  • Generic Drugs
  • Branded Drugs
  • Specialty Medications
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Drug Discount Card Market, By Type

  • 5.1 Introduction
  • 5.2 Pharmacy Benefit Managers (PBMs)
  • 5.3 Retail Pharmacy Chains
  • 5.4 Direct-to-Consumer Platforms
  • 5.5 Non-Profit Organizations
  • 5.6 Other Types

6 Global Drug Discount Card Market, By Therapeutic Category

  • 6.1 Introduction
  • 6.2 Cardiovascular Drugs
  • 6.3 Diabetes Drugs
  • 6.4 Pain Medications
  • 6.5 Mental Health Medications
  • 6.6 Cancer Drugs
  • 6.7 Other Therapeutic Categories

7 Global Drug Discount Card Market, By Sales Channel

  • 7.1 Introduction
  • 7.2 Online
  • 7.3 Offline

8 Global Drug Discount Card Market, By End User

  • 8.1 Introduction
  • 8.2 Generic Drugs
  • 8.3 Branded Drugs
  • 8.4 Specialty Medications
  • 8.5 Other End Users

9 Global Drug Discount Card Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 GoodRx
  • 11.2 SingleCare
  • 11.3 WellCard Savings
  • 11.4 RxSaver
  • 11.5 Optum Perks
  • 11.6 Kroger Prescription Savings Club
  • 11.7 ScriptSave
  • 11.8 Walmart Rx Savings Program
  • 11.9 Prescription Hope
  • 11.10 FamilyWize
  • 11.11 NeedyMeds
  • 11.12 Humana

List of Tables

  • Table 1 Global Drug Discount Card Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Drug Discount Card Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Drug Discount Card Market Outlook, By Pharmacy Benefit Managers (PBMs) (2021-2030) ($MN)
  • Table 4 Global Drug Discount Card Market Outlook, By Retail Pharmacy Chains (2021-2030) ($MN)
  • Table 5 Global Drug Discount Card Market Outlook, By Direct-to-Consumer Platforms (2021-2030) ($MN)
  • Table 6 Global Drug Discount Card Market Outlook, By Non-Profit Organizations (2021-2030) ($MN)
  • Table 7 Global Drug Discount Card Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 8 Global Drug Discount Card Market Outlook, By Therapeutic Category (2021-2030) ($MN)
  • Table 9 Global Drug Discount Card Market Outlook, By Cardiovascular Drugs (2021-2030) ($MN)
  • Table 10 Global Drug Discount Card Market Outlook, By Diabetes Drugs (2021-2030) ($MN)
  • Table 11 Global Drug Discount Card Market Outlook, By Pain Medications (2021-2030) ($MN)
  • Table 12 Global Drug Discount Card Market Outlook, By Mental Health Medications (2021-2030) ($MN)
  • Table 13 Global Drug Discount Card Market Outlook, By Cancer Drugs (2021-2030) ($MN)
  • Table 14 Global Drug Discount Card Market Outlook, By Other Therapeutic Categories (2021-2030) ($MN)
  • Table 15 Global Drug Discount Card Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 16 Global Drug Discount Card Market Outlook, By Online (2021-2030) ($MN)
  • Table 17 Global Drug Discount Card Market Outlook, By Offline (2021-2030) ($MN)
  • Table 18 Global Drug Discount Card Market Outlook, By End User (2021-2030) ($MN)
  • Table 19 Global Drug Discount Card Market Outlook, By Generic Drugs (2021-2030) ($MN)
  • Table 20 Global Drug Discount Card Market Outlook, By Branded Drugs (2021-2030) ($MN)
  • Table 21 Global Drug Discount Card Market Outlook, By Specialty Medications (2021-2030) ($MN)
  • Table 22 North America Drug Discount Card Market Outlook, By Country (2021-2030) ($MN)
  • Table 23 North America Drug Discount Card Market Outlook, By Type (2021-2030) ($MN)
  • Table 24 North America Drug Discount Card Market Outlook, By Pharmacy Benefit Managers (PBMs) (2021-2030) ($MN)
  • Table 25 North America Drug Discount Card Market Outlook, By Retail Pharmacy Chains (2021-2030) ($MN)
  • Table 26 North America Drug Discount Card Market Outlook, By Direct-to-Consumer Platforms (2021-2030) ($MN)
  • Table 27 North America Drug Discount Card Market Outlook, By Non-Profit Organizations (2021-2030) ($MN)
  • Table 28 North America Drug Discount Card Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 29 North America Drug Discount Card Market Outlook, By Therapeutic Category (2021-2030) ($MN)
  • Table 30 North America Drug Discount Card Market Outlook, By Cardiovascular Drugs (2021-2030) ($MN)
  • Table 31 North America Drug Discount Card Market Outlook, By Diabetes Drugs (2021-2030) ($MN)
  • Table 32 North America Drug Discount Card Market Outlook, By Pain Medications (2021-2030) ($MN)
  • Table 33 North America Drug Discount Card Market Outlook, By Mental Health Medications (2021-2030) ($MN)
  • Table 34 North America Drug Discount Card Market Outlook, By Cancer Drugs (2021-2030) ($MN)
  • Table 35 North America Drug Discount Card Market Outlook, By Other Therapeutic Categories (2021-2030) ($MN)
  • Table 36 North America Drug Discount Card Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 37 North America Drug Discount Card Market Outlook, By Online (2021-2030) ($MN)
  • Table 38 North America Drug Discount Card Market Outlook, By Offline (2021-2030) ($MN)
  • Table 39 North America Drug Discount Card Market Outlook, By End User (2021-2030) ($MN)
  • Table 40 North America Drug Discount Card Market Outlook, By Generic Drugs (2021-2030) ($MN)
  • Table 41 North America Drug Discount Card Market Outlook, By Branded Drugs (2021-2030) ($MN)
  • Table 42 North America Drug Discount Card Market Outlook, By Specialty Medications (2021-2030) ($MN)
  • Table 43 North America Drug Discount Card Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 44 Europe Drug Discount Card Market Outlook, By Country (2021-2030) ($MN)
  • Table 45 Europe Drug Discount Card Market Outlook, By Type (2021-2030) ($MN)
  • Table 46 Europe Drug Discount Card Market Outlook, By Pharmacy Benefit Managers (PBMs) (2021-2030) ($MN)
  • Table 47 Europe Drug Discount Card Market Outlook, By Retail Pharmacy Chains (2021-2030) ($MN)
  • Table 48 Europe Drug Discount Card Market Outlook, By Direct-to-Consumer Platforms (2021-2030) ($MN)
  • Table 49 Europe Drug Discount Card Market Outlook, By Non-Profit Organizations (2021-2030) ($MN)
  • Table 50 Europe Drug Discount Card Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 51 Europe Drug Discount Card Market Outlook, By Therapeutic Category (2021-2030) ($MN)
  • Table 52 Europe Drug Discount Card Market Outlook, By Cardiovascular Drugs (2021-2030) ($MN)
  • Table 53 Europe Drug Discount Card Market Outlook, By Diabetes Drugs (2021-2030) ($MN)
  • Table 54 Europe Drug Discount Card Market Outlook, By Pain Medications (2021-2030) ($MN)
  • Table 55 Europe Drug Discount Card Market Outlook, By Mental Health Medications (2021-2030) ($MN)
  • Table 56 Europe Drug Discount Card Market Outlook, By Cancer Drugs (2021-2030) ($MN)
  • Table 57 Europe Drug Discount Card Market Outlook, By Other Therapeutic Categories (2021-2030) ($MN)
  • Table 58 Europe Drug Discount Card Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 59 Europe Drug Discount Card Market Outlook, By Online (2021-2030) ($MN)
  • Table 60 Europe Drug Discount Card Market Outlook, By Offline (2021-2030) ($MN)
  • Table 61 Europe Drug Discount Card Market Outlook, By End User (2021-2030) ($MN)
  • Table 62 Europe Drug Discount Card Market Outlook, By Generic Drugs (2021-2030) ($MN)
  • Table 63 Europe Drug Discount Card Market Outlook, By Branded Drugs (2021-2030) ($MN)
  • Table 64 Europe Drug Discount Card Market Outlook, By Specialty Medications (2021-2030) ($MN)
  • Table 65 Europe Drug Discount Card Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 66 Asia Pacific Drug Discount Card Market Outlook, By Country (2021-2030) ($MN)
  • Table 67 Asia Pacific Drug Discount Card Market Outlook, By Type (2021-2030) ($MN)
  • Table 68 Asia Pacific Drug Discount Card Market Outlook, By Pharmacy Benefit Managers (PBMs) (2021-2030) ($MN)
  • Table 69 Asia Pacific Drug Discount Card Market Outlook, By Retail Pharmacy Chains (2021-2030) ($MN)
  • Table 70 Asia Pacific Drug Discount Card Market Outlook, By Direct-to-Consumer Platforms (2021-2030) ($MN)
  • Table 71 Asia Pacific Drug Discount Card Market Outlook, By Non-Profit Organizations (2021-2030) ($MN)
  • Table 72 Asia Pacific Drug Discount Card Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 73 Asia Pacific Drug Discount Card Market Outlook, By Therapeutic Category (2021-2030) ($MN)
  • Table 74 Asia Pacific Drug Discount Card Market Outlook, By Cardiovascular Drugs (2021-2030) ($MN)
  • Table 75 Asia Pacific Drug Discount Card Market Outlook, By Diabetes Drugs (2021-2030) ($MN)
  • Table 76 Asia Pacific Drug Discount Card Market Outlook, By Pain Medications (2021-2030) ($MN)
  • Table 77 Asia Pacific Drug Discount Card Market Outlook, By Mental Health Medications (2021-2030) ($MN)
  • Table 78 Asia Pacific Drug Discount Card Market Outlook, By Cancer Drugs (2021-2030) ($MN)
  • Table 79 Asia Pacific Drug Discount Card Market Outlook, By Other Therapeutic Categories (2021-2030) ($MN)
  • Table 80 Asia Pacific Drug Discount Card Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 81 Asia Pacific Drug Discount Card Market Outlook, By Online (2021-2030) ($MN)
  • Table 82 Asia Pacific Drug Discount Card Market Outlook, By Offline (2021-2030) ($MN)
  • Table 83 Asia Pacific Drug Discount Card Market Outlook, By End User (2021-2030) ($MN)
  • Table 84 Asia Pacific Drug Discount Card Market Outlook, By Generic Drugs (2021-2030) ($MN)
  • Table 85 Asia Pacific Drug Discount Card Market Outlook, By Branded Drugs (2021-2030) ($MN)
  • Table 86 Asia Pacific Drug Discount Card Market Outlook, By Specialty Medications (2021-2030) ($MN)
  • Table 87 Asia Pacific Drug Discount Card Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 88 South America Drug Discount Card Market Outlook, By Country (2021-2030) ($MN)
  • Table 89 South America Drug Discount Card Market Outlook, By Type (2021-2030) ($MN)
  • Table 90 South America Drug Discount Card Market Outlook, By Pharmacy Benefit Managers (PBMs) (2021-2030) ($MN)
  • Table 91 South America Drug Discount Card Market Outlook, By Retail Pharmacy Chains (2021-2030) ($MN)
  • Table 92 South America Drug Discount Card Market Outlook, By Direct-to-Consumer Platforms (2021-2030) ($MN)
  • Table 93 South America Drug Discount Card Market Outlook, By Non-Profit Organizations (2021-2030) ($MN)
  • Table 94 South America Drug Discount Card Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 95 South America Drug Discount Card Market Outlook, By Therapeutic Category (2021-2030) ($MN)
  • Table 96 South America Drug Discount Card Market Outlook, By Cardiovascular Drugs (2021-2030) ($MN)
  • Table 97 South America Drug Discount Card Market Outlook, By Diabetes Drugs (2021-2030) ($MN)
  • Table 98 South America Drug Discount Card Market Outlook, By Pain Medications (2021-2030) ($MN)
  • Table 99 South America Drug Discount Card Market Outlook, By Mental Health Medications (2021-2030) ($MN)
  • Table 100 South America Drug Discount Card Market Outlook, By Cancer Drugs (2021-2030) ($MN)
  • Table 101 South America Drug Discount Card Market Outlook, By Other Therapeutic Categories (2021-2030) ($MN)
  • Table 102 South America Drug Discount Card Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 103 South America Drug Discount Card Market Outlook, By Online (2021-2030) ($MN)
  • Table 104 South America Drug Discount Card Market Outlook, By Offline (2021-2030) ($MN)
  • Table 105 South America Drug Discount Card Market Outlook, By End User (2021-2030) ($MN)
  • Table 106 South America Drug Discount Card Market Outlook, By Generic Drugs (2021-2030) ($MN)
  • Table 107 South America Drug Discount Card Market Outlook, By Branded Drugs (2021-2030) ($MN)
  • Table 108 South America Drug Discount Card Market Outlook, By Specialty Medications (2021-2030) ($MN)
  • Table 109 South America Drug Discount Card Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 110 Middle East & Africa Drug Discount Card Market Outlook, By Country (2021-2030) ($MN)
  • Table 111 Middle East & Africa Drug Discount Card Market Outlook, By Type (2021-2030) ($MN)
  • Table 112 Middle East & Africa Drug Discount Card Market Outlook, By Pharmacy Benefit Managers (PBMs) (2021-2030) ($MN)
  • Table 113 Middle East & Africa Drug Discount Card Market Outlook, By Retail Pharmacy Chains (2021-2030) ($MN)
  • Table 114 Middle East & Africa Drug Discount Card Market Outlook, By Direct-to-Consumer Platforms (2021-2030) ($MN)
  • Table 115 Middle East & Africa Drug Discount Card Market Outlook, By Non-Profit Organizations (2021-2030) ($MN)
  • Table 116 Middle East & Africa Drug Discount Card Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 117 Middle East & Africa Drug Discount Card Market Outlook, By Therapeutic Category (2021-2030) ($MN)
  • Table 118 Middle East & Africa Drug Discount Card Market Outlook, By Cardiovascular Drugs (2021-2030) ($MN)
  • Table 119 Middle East & Africa Drug Discount Card Market Outlook, By Diabetes Drugs (2021-2030) ($MN)
  • Table 120 Middle East & Africa Drug Discount Card Market Outlook, By Pain Medications (2021-2030) ($MN)
  • Table 121 Middle East & Africa Drug Discount Card Market Outlook, By Mental Health Medications (2021-2030) ($MN)
  • Table 122 Middle East & Africa Drug Discount Card Market Outlook, By Cancer Drugs (2021-2030) ($MN)
  • Table 123 Middle East & Africa Drug Discount Card Market Outlook, By Other Therapeutic Categories (2021-2030) ($MN)
  • Table 124 Middle East & Africa Drug Discount Card Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 125 Middle East & Africa Drug Discount Card Market Outlook, By Online (2021-2030) ($MN)
  • Table 126 Middle East & Africa Drug Discount Card Market Outlook, By Offline (2021-2030) ($MN)
  • Table 127 Middle East & Africa Drug Discount Card Market Outlook, By End User (2021-2030) ($MN)
  • Table 128 Middle East & Africa Drug Discount Card Market Outlook, By Generic Drugs (2021-2030) ($MN)
  • Table 129 Middle East & Africa Drug Discount Card Market Outlook, By Branded Drugs (2021-2030) ($MN)
  • Table 130 Middle East & Africa Drug Discount Card Market Outlook, By Specialty Medications (2021-2030) ($MN)
  • Table 131 Middle East & Africa Drug Discount Card Market Outlook, By Other End Users (2021-2030) ($MN)